Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the ...
One variant showed resistance to antivirals Paxlovid and remdesivir while another strain had mutations associated with a decreased sensitivity to remdesivir and a third antiviral drug, the ...
Xofluza was well tolerated with no new safety signals identified. Every year, seasonal influenza infects an estimated one billion people and causes up to 650,000 deaths globally. On Thursday ...
The drug was well tolerated with no new safety signal identified. Per Roche, this study is the first global phase III study to show a transmission reduction benefit with an antiviral used in the ...